Table 3

Expression of markers in peritumoral capsule and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), N = 80
Marker expression Patients (n) Patients (%) Median survival (months) 5-Year survival (%) P
CD 57
 Low 50 63 38 47 0.797
 High 29 36 123 55
 Missing 1 1
CD 68
 Low 34 43 NR 61 0.057
 High 45 56 31 43
 Missing 1 1
M-CSF
 Low 36 45 75 54 0.608
 High 39 49 36 46
 Missing 5 6
CSF-1R
 Low 36 45 52 49 0.587
 High 37 46 57 47
 Missing 7 9
Ki67
 Low 32 40 NR 74 <0.001
 High 37 46 29 35
 Missing 11 14
TGF-beta
 Low 43 54 52 50 0.906
 High 28 35 31 50
 Missing 9 11
M-CSF and TGF-beta
 Low 24 30 80 57 0.626
 High 42 53 31 45
 Missing 14 18

Abbreviations: NR, not reached.

Sorbye et al.

Sorbye et al. BMC Clinical Pathology 2012 12:7   doi:10.1186/1472-6890-12-7

Open Data